Security Snapshot

Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share (SCTX) Institutional Ownership

CUSIP: 811033109

13F Institutional Holders and Ownership History for Q3 2026

13F reference period

Q3 2026

Institutions Reporting

42

Shares (Excl. Options)

14.5MFull value: 14,499,079 · shares · 30 Sep 2026

Price

$18.40

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+14,495,679
Value change
+$266,561,779
Number of holders
42
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
18,912,423
SEC-reported price per share
$17.44
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SCTX - Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 811033109.
  • 42 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • The headline uses Q3 2026 reported holdings.
  • Quarter-over-quarter comparison is unavailable because the immediately preceding quarter is missing.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 42 institutions filings for Q3 2026.

Open SEC evidence

Security key

811033109

13F reference period

Q3 2026

13F holders

42

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
SCTX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 16% 3,088,888 Aghazadeh Behzad 24 Jul 2026
AH Bio Fund II, L.P. 16% $53,762,724 3,082,725 Marc L. Andreessen 30 Sep 2026
RA CAPITAL MANAGEMENT, L.P. 9.6% 1,802,178 RA Capital Management, L.P. 27 Jul 2026
ELI LILLY & Co 7.3% 1,388,161 ELI LILLY & Co 23 Jul 2026
ORBIMED ADVISORS LLC 7.2% 1,348,825 ORBIMED ADVISORS LLC 27 Jul 2026
As of 30 Sep 2026, 42 institutional investors reported holding
14.5MFull value: 14,499,079 · shares · 30 Sep 2026
shares of Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share (SCTX). This represents 77% of the company’s total
18.91MFull value: 18,912,423 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
74%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
a16z Capital Management, L.L.C. 16% 3,082,725 0.29% $56,737,554
Avoro Capital Advisors LLC 14% 2,598,973 0.49% $47,834,098
RA CAPITAL MANAGEMENT, L.P. 9.5% 1,802,178 0.33% $33,169,086
ORBIMED ADVISORS LLC 7.1% 1,348,825 0.46% $24,825,124
PERCEPTIVE ADVISORS LLC 4.9% 920,341 0.32% $16,938,876
ARK Investment Management LLC 4.2% 786,921 0.08% $14,483,278
BAKER BROS. ADVISORS LP 3.6% 688,691 0.06% $12,675,358
Sanofi 2.6% 500,000 1.5% $9,202,500
VANGUARD CAPITAL MANAGEMENT LLC 2.2% 407,630 0% $7,502,430
FARALLON CAPITAL MANAGEMENT, L.L.C. 2% 380,000 0.04% $6,993,900
ADAGE CAPITAL PARTNERS GP, L.L.C. 2% 380,000 0.01% $6,993,900
GEODE CAPITAL MANAGEMENT, LLC 1.3% 245,412 0% $4,518,022
STATE STREET CORP 0.9% 171,147 0% $3,149,961
Alyeska Investment Group, L.P. 0.79% 150,000 0.01% $2,760,750
Menlo Ventures Management, L.P. 0.52% 97,690 0.75% $1,797,984
TD ASSET MANAGEMENT INC 0.44% 83,342 0% $1,919,366
Amova Asset Management Americas, Inc. 0.4% 74,910 0.02% $1,378,344
VANGUARD PORTFOLIO MANAGEMENT LLC 0.35% 67,039 0% $1,233,853
VANGUARD FIDUCIARY TRUST CO 0.34% 64,267 0% $1,182,834
Longaeva Partners L.P. 0.18% 34,034 0.02% $626,396
BANK OF AMERICA CORP /DE/ 0.15% 27,589 0% $507,776
Point72 Asset Management, L.P. 0.12% 22,771 0% $419,100
GOLDMAN SACHS GROUP INC 0.11% 21,635 0% $398,192
Focus Partners Wealth 0.11% 20,025 0% $368,560
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.07% 13,641 0% $251,063

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
1
Headline period
Q3 2026
Rows shown
1-1 of 1
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 14,499,079 $266,624,356 +$266,561,779 $18.40 42
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .